ALPN
Alpine Immune Sciences, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Mitchell H. Gold
IPO Date
2015-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Alpine Immune Sciences, Inc.
CEO
Mitchell H. Gold
IPO Date
2015-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 17,500 |
| $19.00 |
| 20 May 2024 | Hernday Natasha | director | D-Return | Disposed | 15,000 | $11.07 |
| 20 May 2024 | Hernday Natasha | director | D-Return | Disposed | 7,650 | $13.45 |
| 20 May 2024 | Hernday Natasha | director | D-Return | Disposed | 10,000 | $13.89 |
| 20 May 2024 | Peetz Christopher | director | D-Return | Disposed | 10,000 | $7.43 |
| 20 May 2024 | Peetz Christopher | director | D-Return | Disposed | 17,500 | $19.00 |
| 20 May 2024 | Peetz Christopher | director | D-Return | Disposed | 1,900 | $65.00 |
| 20 May 2024 | Peetz Christopher | director | D-Return | Disposed | 7,650 | $7.91 |
| 20 May 2024 | Peetz Christopher | director | D-Return | Disposed | 7,650 | $4.09 |